These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and immunogenicity of a nicotine conjugate vaccine in current smokers. Hatsukami DK; Rennard S; Jorenby D; Fiore M; Koopmeiners J; de Vos A; Horwith G; Pentel PR Clin Pharmacol Ther; 2005 Nov; 78(5):456-67. PubMed ID: 16321612 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of the nicotine vaccine 3'-AmNic-rEPA (NicVAX) co-administered with varenicline and counselling for smoking cessation: a randomized placebo-controlled trial. Hoogsteder PH; Kotz D; van Spiegel PI; Viechtbauer W; van Schayck OC Addiction; 2014 Aug; 109(8):1252-9. PubMed ID: 24894625 [TBL] [Abstract][Full Text] [Related]
4. [Expecting the antinicotine vaccine]. Didilescu C Pneumologia; 2009; 58(3):177-8. PubMed ID: 19817315 [TBL] [Abstract][Full Text] [Related]
5. A vaccine against nicotine for smoking cessation: a randomized controlled trial. Cornuz J; Zwahlen S; Jungi WF; Osterwalder J; Klingler K; van Melle G; Bangala Y; Guessous I; Müller P; Willers J; Maurer P; Bachmann MF; Cerny T PLoS One; 2008 Jun; 3(6):e2547. PubMed ID: 18575629 [TBL] [Abstract][Full Text] [Related]
6. Nicotine conjugate vaccine as a novel approach to smoking cessation. Ottney AR Pharmacotherapy; 2011 Jul; 31(7):703-13. PubMed ID: 21923458 [TBL] [Abstract][Full Text] [Related]
7. The immunogenicity and safety of a nicotine vaccine in smokers and nonsmokers: results of a randomized, placebo-controlled phase 1/2 trial. Wagena EJ; de Vos A; Horwith G; van Schayck CP Nicotine Tob Res; 2008 Jan; 10(1):213-8. PubMed ID: 18188762 [TBL] [Abstract][Full Text] [Related]
8. Nicotine conjugate vaccines: A novel approach in smoking cessation. Kitchens CM; Foster SL J Am Pharm Assoc (2003); 2012; 52(1):116-8. PubMed ID: 22257625 [No Abstract] [Full Text] [Related]
9. A shot at quitting. Smith SD Minn Med; 2006 Sep; 89(9):9-10. PubMed ID: 17024915 [No Abstract] [Full Text] [Related]
10. Vaccination against nicotine: an emerging therapy for tobacco dependence. Maurer P; Bachmann MF Expert Opin Investig Drugs; 2007 Nov; 16(11):1775-83. PubMed ID: 17970637 [TBL] [Abstract][Full Text] [Related]
11. Enhancing immunogenicity of a 3'aminomethylnicotine-DT-conjugate anti-nicotine vaccine with CpG adjuvant in mice and non-human primates. McCluskie MJ; Pryde DC; Gervais DP; Stead DR; Zhang N; Benoit M; Robertson K; Kim IJ; Tharmanathan T; Merson JR; Davis HL Int Immunopharmacol; 2013 May; 16(1):50-6. PubMed ID: 23562759 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of varenicline combined with nicotine replacement therapy vs varenicline alone for smoking cessation: a randomized clinical trial. Koegelenberg CF; Noor F; Bateman ED; van Zyl-Smit RN; Bruning A; O'Brien JA; Smith C; Abdool-Gaffar MS; Emanuel S; Esterhuizen TM; Irusen EM JAMA; 2014 Jul; 312(2):155-61. PubMed ID: 25005652 [TBL] [Abstract][Full Text] [Related]
13. Niccine®, a nicotine vaccine, for relapse prevention: a phase II, randomized, placebo-controlled, multicenter clinical trial. Tonstad S; Heggen E; Giljam H; Lagerbäck PÅ; Tønnesen P; Wikingsson LD; Lindblom N; de Villiers S; Svensson TH; Fagerström KO Nicotine Tob Res; 2013 Sep; 15(9):1492-501. PubMed ID: 23471101 [TBL] [Abstract][Full Text] [Related]
17. Prediction of abstinence at 10 weeks based on smoking status at 2 weeks during a quit attempt: secondary analysis of two parallel, 10-week, randomized, double-blind, placebo-controlled clinical trials of 21-mg nicotine patch in adult smokers. Ferguson SG; Gitchell JG; Shiffman S; Sembower MA Clin Ther; 2009 Sep; 31(9):1957-65. PubMed ID: 19843485 [TBL] [Abstract][Full Text] [Related]
18. Which smokers are helped to give up smoking using transdermal nicotine patches? Results from a randomized, double-blind, placebo-controlled trial. Yudkin PL; Jones L; Lancaster T; Fowler GH Br J Gen Pract; 1996 Mar; 46(404):145-8. PubMed ID: 8731618 [TBL] [Abstract][Full Text] [Related]